PASSKEY Trademark

Trademark Overview

On Thursday, October 5, 2023, a trademark application was filed for PASSKEY with the United States Patent and Trademark Office. The USPTO has given the PASSKEY trademark a serial number of 98976637. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Monday, September 22, 2025. This trademark is owned by Passkey Therapeutics, Inc.. The PASSKEY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of pharmaceuticals
passkey

General Information

Serial Number98976637
Word MarkPASSKEY
Filing DateThursday, October 5, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateMonday, September 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements

Goods and ServicesResearch and development services in the field of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code042
First Use Anywhere DateMonday, September 30, 2024
First Use In Commerce DateMonday, September 30, 2024

Trademark Owner History

Party NamePasskey Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NamePasskey Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Saturday, October 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 25, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 9, 2023NEW APPLICATION ENTERED
Saturday, May 25, 2024NON-FINAL ACTION E-MAILED
Saturday, May 25, 2024ASSIGNED TO EXAMINER
Wednesday, June 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 1, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, May 25, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, June 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Friday, February 7, 2025SOU TEAS EXTENSION RECEIVED
Friday, February 7, 2025SOU EXTENSION 1 FILED
Friday, February 7, 2025SOU EXTENSION 1 GRANTED
Friday, February 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 12, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, March 12, 2025TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, March 12, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, June 10, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 22, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 12, 2025USE AMENDMENT FILED
Tuesday, September 23, 2025SOU TEAS EXTENSION RECEIVED
Monday, September 22, 2025DIVISIONAL PROCESSING COMPLETE

Related Keywords

passkey pharmaceuticals field services development research